Am J Epidemiol

1. CLASEN JL, Jonsdottir B, Vehik K, Lynch KF, et al
   Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study.
   Am J Epidemiol. 2026;195:2111-2120.
   

   >> Share

   
   

   
   Am J Ophthalmol

2. BORKAR DS, Ford CB, Song A, Lusk JB, et al
   Neighborhood Socioeconomic Deprivation and Adherence to Diabetic Retinopathy Screening Guidelines.
   Am J Ophthalmol. 2026 Aug 5:S0002-9394(26)00429.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

3. TANAKA M, Kanazashi M, Nakanishi R, Kondo H, et al
   Astaxanthin attenuates skeletal muscle atrophy and mitochondrial dysfunction in streptozotocin-induced diabetic rats.
   Biochem Biophys Res Commun. 2026;832:154374.
   

   >> Share

   
   

   
   BMJ

4. SCIBILIA R, Cleal B, Dickinson JK, Sethi J, et al
   Diabetes advocacy campaigns should focus on living a life, not fighting a battle.
   BMJ. 2026;394:e100525.
   

   >> Share

   
   
5. KRUGER N, Schneeweiss S, Wang SV
   Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study.
   BMJ. 2026;394:e100011.
   

   >> Share

   
   
6. TANNE JH
   Doctors ejected from diabetes conference for criticising US administration face internal investigation.
   BMJ. 2026;394:e100475.
   

   >> Share

   
   

   
   Diabet Med

7. CHEN M, Wei S, Sun J, Zhang C, et al
   Ecological momentary assessment in adolescents with type 1 diabetes mellitus: A scoping review.
   Diabet Med. 2026 Aug 7:e70433. doi: 10.1111/dme.70433.
   

   >> Share

   
   
8. LINDGREEN P, Clausen L, Wisting L, Ismail K, et al
   Commentary: Central themes and insights from the Diabetes and Disordered Eating Conference 2025.
   Diabet Med. 2026 Aug 6:e70431. doi: 10.1111/dme.70431.
   

   >> Share

   
   
9. LEE WC, Porterfield LR, Vaughan EM, Raji M, et al
   Compare diabetes care patterns by primary care accessibility during the COVID-19 pandemic.
   Diabet Med. 2026 Aug 3:e70442. doi: 10.1111/dme.70442.
   

   >> Share

   
   
10. MARFO R, Miezah D, Abubakari M, Assuah E, et al
    Social support and diabetes self-care among African American adults with type 2 diabetes: A systematic review.
    Diabet Med. 2026 Aug 2:e70414. doi: 10.1111/dme.70414.
    

    >> Share

    
    

    
    Diabetes

11. SAAVEDRA D, Mittal R, Blaschke C, Rech Tondin A, et al
    The Intersection of Immunosenescence, Cellular Senescence, and Type 1 Diabetes: Paving the Way for Future Interventions.
    Diabetes. 2026 Aug 6:db260159. doi: 10.2337/db26-0159.
    

    >> Share

    
    
12. CHAVEZ MD, Mahr AR, Wilkins HM, Tse HM, et al
    Metabolic Blockade of Glycolysis Diminishes Autoreactive CD4 T-Cell Effector Responses in Type 1 Diabetes.
    Diabetes. 2026 Aug 3:db251152. doi: 10.2337/db25-1152.
    

    >> Share

    
    

    
    Diabetes Care

13. DUFOUR AB, Bouxsein ML, Gao M, Kiel DP, et al
    Type 2 Diabetes and Longitudinal Changes in Cortical and Trabecular Bone Density, Microarchitecture, and Strength: The Framingham Study.
    Diabetes Care. 2026 Aug 5:dc260846. doi: 10.2337/dc26-0846.
    

    >> Share

    
    
14. HE JH, Malek ND, Zeger SL, Echouffo-Tcheugui JB, et al
    Continuous Glucose Monitoring Metrics and Risks of Severe Hypoglycemia and Diabetic Ketoacidosis in Type 1 Diabetes: A Pooled Analysis.
    Diabetes Care. 2026 Aug 6:dc261042. doi: 10.2337/dc26-1042.
    

    >> Share

    
    
15. ZAITOON H
    A Pediatric Therapeutic Gap in the Emerging Stage-Specific Treatment of Type 1 Diabetes.
    Diabetes Care. 2026 Aug 7:dc261566. doi: 10.2337/dc26-1566.
    

    >> Share

    
    
16. ADDALA A, Cabrera S, Cuthbertson D, Libman I, et al
    Islet Autoantibody Patterns Vary by Race and Ethnicity and Area Deprivation Index for Individuals at Risk for Type 1 Diabetes.
    Diabetes Care. 2026 Aug 7:dc260387. doi: 10.2337/dc26-0387.
    

    >> Share

    
    

    
    Diabetes Obes Metab

17. KOUTROUKAS V, Tziannou A, Thomas JJC, Martine-Edith G, et al
    Factors Associated With Progression From Level 1 to Level 2 Sensor-Detected Hypoglycaemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: A Post Hoc Analysis From the Hypo-METRICS Study.
    Diabetes Obes Metab. 2026 Aug 4. doi: 10.1111/dom.71172.
    

    >> Share

    
    
18. TU H, Ju C, McGurnaghan SJ, Blackbourn LAK, et al
    Absence of Interaction Between 5alpha-Reductase Inhibitors and Glucocorticoids on Incidence of Myocardial Infarction in People With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Aug 3. doi: 10.1111/dom.71148.
    

    >> Share

    
    
19. HE P, Wang M, Mei H, Liu Y, et al
    Sodium Butyrate Attenuates Renal Fibrosis by Regulating Glycolysis and Histone H4K12 Lactylation in Diabetic Kidney Disease.
    Diabetes Obes Metab. 2026 Aug 2. doi: 10.1111/dom.71166.
    

    >> Share

    
    
20. SAVASTIO S, Scaramuzza AE, Pozzi E, Castorani V, et al
    Socioeconomic and Linguistic Factors in Paediatric Type 1 Diabetes: Exploring Glycemic Outcomes, Technology Use, and Residual Beta-Cell Function in Migrant-Background Populations.
    Diabetes Obes Metab. 2026 Aug 2. doi: 10.1111/dom.71167.
    

    >> Share

    
    
21. IQBAL A, Dahimi H, Preux P, Lespagnol E, et al
    Identification of Activity, Insulin, and Dietary Thresholds Associated With Exercise-Related Hypoglycaemia and Hyperglycaemia in Children With Type 1 Diabetes: A Free-Living Study Using Explainable Machine Learning.
    Diabetes Obes Metab. 2026 Aug 2. doi: 10.1111/dom.71165.
    

    >> Share

    
    
22. FORTIN E, Norhammar A, Stadler D, Herzog PL, et al
    alpha-Hydroxybutyrate Association With Incident Type 2 Diabetes Over 10 Years Across Different Glycemic States.
    Diabetes Obes Metab. 2026 Aug 2. doi: 10.1111/dom.71155.
    

    >> Share

    
    
23. SPRINGER C, Sill S, Binsch C, Schoen T, et al
    Exercise Resistance in Obese Male NZO Mice Manifests as Local Muscle Remodelling Without Glycaemic Improvements.
    Diabetes Obes Metab. 2026;28:8660-8674.
    

    >> Share

    
    
24. SILVA JPMRJ, Nogueira BV, Sartori DL, da Silva JRC, et al
    Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026;28:8627-8636.
    

    >> Share

    
    
25. AMBIKA GOPALAKRISHNAN U, Joshi A, Kumar H, Giri R, et al
    Semaglutide Injection Once-Weekly for Weight Management in Adults: Results From A Randomized Phase III, Active-Controlled Study.
    Diabetes Obes Metab. 2026;28:8602-8612.
    

    >> Share

    
    
26. GERSTEIN HC, Labiba Z, Hess S, Mohammedi K, et al
    A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at Baseline.
    Diabetes Obes Metab. 2026;28:8595-8601.
    

    >> Share

    
    
27. RAASCHOU-ODDERSHEDE D, Schwarz CR, Kovalova T, Branch KR, et al
    Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O Trial.
    Diabetes Obes Metab. 2026;28:8552-8559.
    

    >> Share

    
    
28. MONAMI M, Ragghianti B, Mannucci E
    Positioning Incretin-Based and Next-Generation Obesity Management Medications: A Methodological Framework for a Series of Systematic Reviews and Network Meta-Analyses.
    Diabetes Obes Metab. 2026;28:7768-7778.
    

    >> Share

    
    
29. KOKKINOS A, Thethi T, Lee CJ, Neff LM, et al
    Tirzepatide Efficacy and Tolerability According to Early Weight Response: A Post Hoc Analysis of the SURMOUNT-1 and SURMOUNT-2 Trials.
    Diabetes Obes Metab. 2026;28:8367-8377.
    

    >> Share

    
    
30. KIM S, Barthel A, Smurzynski M, MacEwan J, et al
    Prevalence of Obesity and Related Conditions and GLP-1 Use in Medicare Fee-for-Service Beneficiaries.
    Diabetes Obes Metab. 2026;28:8398-8406.
    

    >> Share

    
    
31. HASEBE M, Su CY, Yabe D, Yoshiji S, et al
    Cardiovascular Efficacy of GLP-1 Receptor Agonists by Kidney Function: An Updated Meta-Analysis of Randomized Trials Including the SOUL Trial.
    Diabetes Obes Metab. 2026;28:8407-8417.
    

    >> Share

    
    
32. KAUR R, Singh A
    Efficacy and Safety of GLP-1 Receptor Agonists on Combined Cardiovascular and Renal Outcomes in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026;28:8337-8346.
    

    >> Share

    
    
33. GUGLIANDOLO S, Morciano C, Guarneri A, Sorice GP, et al
    A Four-Week Treatment With Dapagliflozin Is Associated With a Reduction in Insulin-Stimulated Renal Cortical Glucose Uptake: A Post Hoc Analysis From a Pilot Study.
    Diabetes Obes Metab. 2026;28:8329-8336.
    

    >> Share

    
    
34. CHOI HS, Heo J, Won S, Suh SH, et al
    Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Gout Risk: A Population-Based Comparative Cohort Study With Genetic Evidence From Mendelian Randomisation.
    Diabetes Obes Metab. 2026;28:8230-8241.
    

    >> Share

    
    
35. COSSON E, Haas LC, Levrat-Guillen F
    The Role of Continuous Glucose Monitoring in Managing Hyperglycaemia First Detected in Pregnancy: A Narrative Review.
    Diabetes Obes Metab. 2026;28:7719-7736.
    

    >> Share

    
    
36. RAKHSHA SS, Shahinfar H, Ebrahimi-Mousavi S, Kosari A, et al
    Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and Network Meta-Analysis.
    Diabetes Obes Metab. 2026;28:7689-7704.
    

    >> Share

    
    
37. DZIEWIERZ A, Kulicka N, Stolarska K, Ahmatovic A, et al
    Temporal Trends and Clinical Characteristics of Incretin-Based Therapy Use in Women With Polycystic Ovary Syndrome: A Real-World Cohort Study From a Polish Private Healthcare Network.
    Diabetes Obes Metab. 2026;28:8045-8056.
    

    >> Share

    
    
38. LIU S, Cao B, Lin C, Chen W, et al
    Weight Changes With Lower Doses of Semaglutide in Clinical Practice: Findings From the Chinese HARMONY Cohort.
    Diabetes Obes Metab. 2026;28:8025-8033.
    

    >> Share

    
    
39. MCGILL JB, Green JB, Heerspink HJL, Mann JFE, et al
    Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.
    Diabetes Obes Metab. 2026;28:7964-7973.
    

    >> Share

    
    
40. RO AE, Choi JM, Morales C, Kuhn NT, et al
    T2D Management Among a Community Clinic Patient Sample After California's May 2022 Medicaid Expansion.
    Diabetes Obes Metab. 2026;28:7974-7981.
    

    >> Share

    
    
41. JIANG Y, Gu L, Ma Y, Qu Y, et al
    Abnormal Glycaemic Fluctuations Associated With Early Microvascular Changes in the Retina and Choroid of Nondiabetic Adults.
    Diabetes Obes Metab. 2026;28:7864-7874.
    

    >> Share

    
    
42. MULLER P, Wray J, Rahman M, Hawkins J, et al
    SGLT2 Inhibitor Use in Type 2 Diabetes in England: A Population-Based Cross-Sectional Study of Uptake of NICE Guidance.
    Diabetes Obes Metab. 2026 Aug 4. doi: 10.1111/dom.71010.
    

    >> Share

    
    
43. JI L, Andersen JD, Benamar M, Ponzani P, et al
    Efficacy and Hypoglycaemia Outcomes With Once-Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1-3 Trials.
    Diabetes Obes Metab. 2026 Aug 5. doi: 10.1111/dom.70895.
    

    >> Share

    
    
44. AUDRAIN E, Bel Lassen P, Bellanne-Chantelot C, Vantyghem MC, et al
    Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National Study.
    Diabetes Obes Metab. 2026 Aug 6. doi: 10.1111/dom.71169.
    

    >> Share

    
    
45. YU YH, Zhang Q, Zapata-Bravo E, Platt RW, et al
    Time to Insulin Initiation Among Patients With Type 2 Diabetes Treated With Second-Line Antidiabetic Drugs.
    Diabetes Obes Metab. 2026 Aug 6. doi: 10.1111/dom.71182.
    

    >> Share

    
    
46. YI TW, Sikirica S, Rompicherla S, Thapa S, et al
    The Impact of Kidney Function on Diabetic Ketoacidosis and Severe Hypoglycemia Among Adults With Type 1 Diabetes: Insights From the T1D Exchange Real-World Observation Study.
    Diabetes Obes Metab. 2026 Aug 6. doi: 10.1111/dom.71191.
    

    >> Share

    
    
47. CHRISTENSEN JH, Petersen GL, Kaur S, Lind A, et al
    Long-Term Follow-Up Incidence of Type 1 Diabetes and Associated Autoimmune Diseases in First-Degree Relatives.
    Diabetes Obes Metab. 2026 Aug 6. doi: 10.1111/dom.71194.
    

    >> Share

    
    

    
    Diabetologia

48. DE WIT DF, Fuhri Snethlage CM, Levels JHM, Rampanelli E, et al
    High prevalence of low faecal elastase levels in individuals with type 1 diabetes is associated with diabetes duration but not with marked alterations in food intake or clinical symptoms.
    Diabetologia. 2026 Aug 8. doi: 10.1007/s00125-026-06829.
    

    >> Share

    
    
49. KIMURA T, Kidokoro K, Iwamoto Y, Iwamoto H, et al
    A GLP-1 receptor agonist enhances islet microvascular flow through nitric oxide-dependent mechanisms in a diabetic mouse model: investigation using intravital two-photon imaging.
    Diabetologia. 2026 Aug 7. doi: 10.1007/s00125-026-06825.
    

    >> Share

    
    
50. QADRI SF
    Screening and diagnosis of liver disease in diabetes: a guide and evidence-based assessment.
    Diabetologia. 2026 Aug 6. doi: 10.1007/s00125-026-06816.
    

    >> Share

    
    
51. FUZAK NUNZIATO M, Yan B, Schliep KC, Farland LV, et al
    Endometriosis subtypes and risk of type 2 diabetes: the Advancing Research on Cardiovascular Health and Endometriosis Study (ARCHES) retrospective cohort study.
    Diabetologia. 2026 Aug 6. doi: 10.1007/s00125-026-06828.
    

    >> Share

    
    
52. FLOCKHART M, Svensson M, Ehtesham E, Ryberg M, et al
    Concurrent training is associated with enhanced post-exercise ceramide clearance and fat oxidation capacity in individuals with type 2 diabetes following lifestyle intervention.
    Diabetologia. 2026 Aug 5. doi: 10.1007/s00125-026-06820.
    

    >> Share

    
    
53. JORGENSEN IL, Damm P, Andersen MK, Reim PK, et al
    Predicting future risk of type 1 and type 2 diabetes after gestational diabetes mellitus using polygenic scores: a cohort study.
    Diabetologia. 2026 Aug 4. doi: 10.1007/s00125-026-06824.
    

    >> Share

    
    
54. LEJONBERG C, Czuba T, Bennet L, Coral DE, et al
    Incidence and independent risk factors for heart failure in a population-based cohort of 19,892 individuals with newly diagnosed diabetes.
    Diabetologia. 2026 Aug 3. doi: 10.1007/s00125-026-06823.
    

    >> Share

    
    
55. GHOSH A, Dutta K, Bhatt SP, Ansari IA, et al
    Metabolic implications of hepatic, pancreatic and abdominal adipose tissue depots in Asian Indians across normoglycaemia, prediabetes and type 2 diabetes.
    Diabetologia. 2026 Aug 1. doi: 10.1007/s00125-026-06807.
    

    >> Share

    
    
56. KAHL S, Caussy C, Cusi K
    Is MASLD an independent risk factor for micro- and macrovascular complications of diabetes? A critical reappraisal and future directions.
    Diabetologia. 2026 Aug 1. doi: 10.1007/s00125-026-06817.
    

    >> Share

    
    

    
    Invest Ophthalmol Vis Sci

57. DA SILVA RA, Ferreira LPS, Roda VMP, Dos Santos DD, et al
    Annexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:12.
    

    >> Share

    
    
58. ZHENG F, Hong Y, Chua J, Foo SH, et al
    Macular Choriocapillaris and Retinal Microvascular Alterations Across the Prediabetes-Early Type 2 Diabetes Continuum.
    Invest Ophthalmol Vis Sci. 2026;67:16.
    

    >> Share

    
    
59. LARSEN PP, Linard M, Schweitzer C, Delyfer MN, et al
    Exploring Endotoxemia in Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:14.
    

    >> Share

    
    

    
    J Am Coll Cardiol

60. PANDEY A, Patel KV
    Pharmacotherapy for Management of Type 2 Diabetes and CKM Syndrome: SGLT2 Inhibitors and GLP-1-Based Therapies for All vs a Risk-Based Approach?
    J Am Coll Cardiol. 2026;88:559-562.
    

    >> Share

    
    
61. CAVENDER MA, Marx N, Mulvagh SL, Deanfield JE, et al
    Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease.
    J Am Coll Cardiol. 2026;87:1369-1373.
    

    >> Share

    
    
62. GONG J, Chiu N, Clinch KA, Qian Y, et al
    Treatment of Cardiometabolic Risk Factors Among U.S. Adults With Cardiovascular-Kidney-Metabolic Syndrome.
    J Am Coll Cardiol. 2026 Jun 17:S0735-1097(26)06350.
    

    >> Share

    
    

    
    J Am Soc Nephrol

63. HARTSELL SE, Wei G, Singh R, Throolin M, et al
    Comparative Effectiveness of SGLT2 Inhibitor and GLP-1 Receptor Agonist on Kidney and Cardiovascular Outcomes by Kidney Failure Risk.
    J Am Soc Nephrol. 2026;37:1733-1747.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

64. IZUMIHARA R, Nomoto H, Chiba K, Kameda H, et al
    Relationship between Metabolic Remodeling of Pancreatic beta-cells and Pancreatic Histology in Type 2 Diabetes.
    J Clin Endocrinol Metab. 2026 Aug 5:dgag315. doi: 10.1210.
    

    >> Share

    
    

    
    J Clin Invest

65. SHARMA RB, Darko C, Wang Y, Castro TA, et al
    JNK and p53 cause human and mouse beta cell death during excessive unfolded protein response.
    J Clin Invest. 2026;136:e193035.
    

    >> Share

    
    
66. PALOZZI JM, Puigserver P
    Diabetic and ER-stressed pancreatic islet beta cells are in need of some JNK removal.
    J Clin Invest. 2026;136:e209808.
    

    >> Share

    
    

    
    J Diabetes Complications

67. HORNBRINCK E, Lundqvist MH, Lampa E, Eriksson JW, et al
    Risk factors for microvascular complications in childhood-onset type 1 diabetes: impact of perinatal factors, age at onset and glycemic control over more than 30 years of follow-up.
    J Diabetes Complications. 2026;40:109390.
    

    >> Share

    
    

    
    J Hypertens

68. ALYAS JT, Nielsen SF, Buus NH
    Explaining blood pressure reduction heterogeneity in sodium-glucose cotransporter-2 inhibitor trials: a meta-analysis stratified by patient characteristics.
    J Hypertens. 2026;44:1487-1498.
    

    >> Share

    
    

    
    J Nutr

69. KATSIGIANNIS G, Panoutsopoulos G, Perrea A, Detopoulou P, et al
    Comparison of ChatGPT and dietitians in formulating diet plans and recommendations for patients with cardiometabolic diseases.
    J Nutr. 2026 Jun 12:101667. doi: 10.1016/j.tjnut.2026.101667.
    

    >> Share

    
    

    
    J Pediatr

70. STROHECKER KM, Erickson T, Kruse L
    Prurigo Pigmentosa in the Setting of Diabetic Ketoacidosis.
    J Pediatr. 2026 Aug 3:115273. doi: 10.1016/j.jpeds.2026.115273.
    

    >> Share

    
    

    
    JAMA

71. GAO L, Jiang H, Cai H, Tian J, et al
    Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical Trial.
    JAMA. 2026;336:377-388.
    

    >> Share

    
    

    
    Obstet Gynecol

72. FIELD C, Grobman WA, Mast D, Wu J, et al
    Diabetes Testing Immediately Postpartum After Gestational Diabetes Mellitus: A Randomized Controlled Trial: Correction.
    Obstet Gynecol. 2026 Aug 7. doi: 10.1097/AOG.0000000000006412.
    

    >> Share

    
    

    
    Ophthalmology

73. ABDI A, Alshaikhsalama A, Zaidi Z, Alsoudi AF, et al
    Systemic Interleukin-6 Inhibition and Risk of Diabetic Retinopathy Development and Progression.
    Ophthalmology. 2026 Aug 3:S0161-6420(26)00534.
    

    >> Share

    
    

    
    PLoS Genet

74. 
    Correction: Meta-evolutionary exome analysis identifies novel type 2 diabetes mellitus genes in the UK Biobank and All of Us.
    PLoS Genet. 2026;22:e1012265.
    

    >> Share

    
    

    
    PLoS Med

75. APOSTOLOU A, Simfukwe R, Saint A, Mushani B, et al
    Adherence to medications, lifestyle advice, and self-monitoring for type 2 diabetes and hypertension in sub-Saharan Africa: A systematic review, meta-analysis, and interactive network analysis.
    PLoS Med. 2026;23:e1005189.
    

    >> Share

    
    

    
    PLoS One

76. KIM M, Park YH
    Seasonal variation in the incidence of vitreous hemorrhage in proliferative diabetic retinopathy.
    PLoS One. 2026;21:e0355497.
    

    >> Share

    
    
77. THEW HZ, Lim PY, Tan TQ, Goh JH, et al
    Effectiveness of web-based educational videos on enhancing diabetes knowledge and empowerment among type 2 diabetes patients in primary care: A randomized controlled trial.
    PLoS One. 2026;21:e0355192.
    

    >> Share

    
    
78. ALKALI NH, Uloko AE, Osaigbovo GO, Bakari AG, et al
    Prevalence, treatment rates and control of dyslipidemia among diabetes patients in northern Nigeria: A cross-sectional, multicenter study.
    PLoS One. 2026;21:e0346350.
    

    >> Share

    
    
79. MOTAGANAHALLI S, Vogrin S, Richards T, Peel T, et al
    Pilot randomised controlled trial of probe to bone diabetic foot ulcer therapy (PROBE-DFU trial) - Study protocol.
    PLoS One. 2026;21:e0354611.
    

    >> Share

    
    
80. FERNANDES FCGM, Bezerra RA, Barbosa IR
    Evaluation of the adequacy of care for individuals with diabetes in Brazil: The intersection between gender, race, and socioeconomic profile.
    PLoS One. 2026;21:e0349257.
    

    >> Share

    
    
81. YI Y, Chen Y, Feng S, Lu F, et al
    The association between atherogenic index of plasma, cumulative atherogenic index of plasma and type 2 diabetes mellitus with chronic kidney disease among older Chinese adults: Findings from the CHARLS study.
    PLoS One. 2026;21:e0355200.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

82. PLESNER A, Cao P, Raleigh DP, Abedini A, et al
    Aggregation kinetics define the temporal window of IAPP proteotoxicity.
    Proc Natl Acad Sci U S A. 2026;123:e2615786123.
    

    >> Share

    
    

    
    Retina

83. YUN JS, NaPier E, Hosseini H, Au AC, et al
    Vitrectomy for Proliferative Diabetic Retinopathy with Asteroid Hyalosis: Contemporary Outcomes and Challenges.
    Retina. 2026 Aug 6. doi: 10.1097/IAE.0000000000004952.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share